JP2013500001A5 - - Google Patents

Download PDF

Info

Publication number
JP2013500001A5
JP2013500001A5 JP2012520964A JP2012520964A JP2013500001A5 JP 2013500001 A5 JP2013500001 A5 JP 2013500001A5 JP 2012520964 A JP2012520964 A JP 2012520964A JP 2012520964 A JP2012520964 A JP 2012520964A JP 2013500001 A5 JP2013500001 A5 JP 2013500001A5
Authority
JP
Japan
Prior art keywords
gmip
ikbke
endometrial cancer
level
p4hb
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012520964A
Other languages
English (en)
Japanese (ja)
Other versions
JP5934093B2 (ja
JP2013500001A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/004550 external-priority patent/WO2011009637A2/en
Publication of JP2013500001A publication Critical patent/JP2013500001A/ja
Publication of JP2013500001A5 publication Critical patent/JP2013500001A5/ja
Application granted granted Critical
Publication of JP5934093B2 publication Critical patent/JP5934093B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012520964A 2009-07-24 2010-07-23 子宮内膜がんのマーカー Expired - Fee Related JP5934093B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09166398 2009-07-24
EP09166398.9 2009-07-24
PCT/EP2010/004550 WO2011009637A2 (en) 2009-07-24 2010-07-23 Markers for endometrial cancer

Publications (3)

Publication Number Publication Date
JP2013500001A JP2013500001A (ja) 2013-01-07
JP2013500001A5 true JP2013500001A5 (enExample) 2013-09-05
JP5934093B2 JP5934093B2 (ja) 2016-06-15

Family

ID=42751506

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012520964A Expired - Fee Related JP5934093B2 (ja) 2009-07-24 2010-07-23 子宮内膜がんのマーカー

Country Status (17)

Country Link
US (2) US9046522B2 (enExample)
EP (2) EP2848700B1 (enExample)
JP (1) JP5934093B2 (enExample)
KR (1) KR101828290B1 (enExample)
CN (2) CN105132529A (enExample)
AU (1) AU2010275699B2 (enExample)
BR (1) BR112012001469B1 (enExample)
CA (1) CA2767914C (enExample)
DK (1) DK2456889T3 (enExample)
ES (2) ES2523683T3 (enExample)
HR (1) HRP20141062T1 (enExample)
IN (1) IN2012DN00707A (enExample)
MX (1) MX2012000921A (enExample)
PL (1) PL2456889T3 (enExample)
PT (1) PT2456889E (enExample)
RU (1) RU2596394C2 (enExample)
WO (1) WO2011009637A2 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2012DN00707A (enExample) * 2009-07-24 2015-06-19 Geadic Biotec Aie
EP2758777B1 (en) * 2011-09-22 2018-02-07 Memorial Sloan-Kettering Cancer Center Detecting ovarian cancer
EP2787350A1 (en) * 2013-04-05 2014-10-08 Atlas Antibodies AB ASRGL1 in endometrial cancer
KR102113310B1 (ko) * 2013-09-03 2020-05-20 아주대학교 산학협력단 암 세포 분리용 조성물, 키트 및 이를 이용한 분리 방법
EP3180611B1 (en) 2014-08-12 2025-04-09 NextGen Jane, Inc. System and method for monitoring health based on collected bodily fluid
CN106714835A (zh) * 2014-09-17 2017-05-24 默克专利股份公司 治疗骨转移疾病的方法、其药物以及预测治疗骨转移疾病的临床结果的方法
CN107102141A (zh) * 2016-02-23 2017-08-29 中国科学院生物物理研究所 分子标记物cd71及在子宫内膜癌诊断、分期及预后中的应用
WO2017180909A1 (en) 2016-04-13 2017-10-19 Nextgen Jane, Inc. Sample collection and preservation devices, systems and methods
EP4610655A3 (en) * 2016-05-04 2025-12-10 Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca Markers of endometrial cancer
GB201702392D0 (en) * 2017-02-14 2017-03-29 Univ Edinburgh Methods for cancer diagnosis using a gene expression signature
CN108732349A (zh) * 2017-04-20 2018-11-02 中国科学院上海生命科学研究院 Lta4h作为指示肝内结节及早期预警肝癌的生物标志物
CN108732350A (zh) * 2017-04-20 2018-11-02 中国科学院上海生命科学研究院 Pla2g6作为指示肝内结节及早期预警肝癌的生物标志物
CN108732351A (zh) * 2017-04-20 2018-11-02 中国科学院上海生命科学研究院 Eps8l2作为指示肝内结节及早期预警肝癌的生物标志物
CN109085359A (zh) * 2017-06-13 2018-12-25 中国医学科学院肿瘤医院 血清蛋白标志物组合在结直肠癌筛查和诊治中的应用
CN117288953A (zh) * 2017-07-21 2023-12-26 瓦尔德西布伦大学医院基金会研究所 一种子宫内膜癌的预后方法
WO2019239431A1 (en) * 2018-06-13 2019-12-19 Tzar Management Technology Private Limited Method for analysing pluripotent stem cell biomarkers, and implementations thereof
CN109097462B (zh) * 2018-09-10 2022-01-11 青岛市海慈医疗集团 Ap1m2基因作为诊断青光眼的分子标志物的应用
WO2020130190A1 (ko) * 2018-12-20 2020-06-25 경상대학교병원 신장암의 발병 위험성 예측 또는 진단을 위한 정보제공방법
CN113329697A (zh) * 2019-01-23 2021-08-31 吉娜-生命诊断有限公司 癌症诊断和监测设备、其系统和方法
CN109797217A (zh) * 2019-03-27 2019-05-24 河北医科大学第二医院 帕金森生物标志物及其在制备检测产品中的应用
CN109811058B (zh) * 2019-03-31 2021-11-12 青岛泱深生物医药有限公司 与宫颈疾病发生发展相关的生物标志物及其应用
WO2022226381A1 (en) * 2021-04-22 2022-10-27 H. Lee Moffitt Cancer Center And Research Institute, Inc. Diagnostic to support clinical trial matching and exploratory biomarker analyses in cancer patients
CN114317750B (zh) * 2021-12-29 2024-05-14 上海市第十人民医院 一种卵巢癌生物标志物及其在制备用于卵巢癌腹水转移疾病的药物或试剂盒中的应用
KR102584898B1 (ko) * 2022-10-24 2023-10-04 연세대학교 산학협력단 자궁내막암 진단 방법 및 이를 이용한 키트
WO2024192014A1 (en) * 2023-03-12 2024-09-19 Novelna Inc. Endometrial cancer detection proteins and methods of use thereof

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
AUPO573697A0 (en) 1997-03-20 1997-04-10 Prince Henry's Institute Of Medical Research Diagnosis of endometrial cancer
US7014996B1 (en) * 1998-10-02 2006-03-21 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers
AUPQ219799A0 (en) 1999-08-13 1999-09-02 R. Lurie Pty Ltd Apparatus for obtaining potological samples
US6884578B2 (en) 2000-03-31 2005-04-26 Affymetrix, Inc. Genes differentially expressed in secretory versus proliferative endometrium
RU2232397C2 (ru) * 2002-04-03 2004-07-10 НИИ онкологии им. проф. Н.Н. Петрова Способ ранней диагностики патологических состояний эндометрия
AU2003253860A1 (en) * 2002-07-10 2004-01-23 The Regents Of The University Of Michigan Expression profile of lung cancer
US7640114B2 (en) * 2003-05-21 2009-12-29 The Wistar Institute Of Anatomy & Biology Method of diagnosis of cancer based on gene expression profiles in cells
WO2005035746A2 (en) * 2003-10-02 2005-04-21 Xantos Biomedicine Ag Medical use of tbk-1 or of inhibitors thereof
JP5629894B2 (ja) 2004-12-07 2014-11-26 国立大学法人大阪大学 甲状腺乳頭癌を診断するための新規のマーカー
EP2295601A1 (en) * 2005-02-10 2011-03-16 Oncotherapy Science, Inc. Method of diagnosing bladder cancer
EP1931322B1 (en) 2005-09-07 2012-08-15 Merck Serono SA Ikk inhibitors for the treatment of endometriosis
WO2007072220A2 (en) * 2005-09-12 2007-06-28 Aurelium Biopharma Inc. Focused microarray and methods of diagnosing cancer
CN101384903A (zh) * 2006-02-09 2009-03-11 南佛罗里达大学 利用bcl-2水平的增高检测癌肿
US20070287158A1 (en) * 2006-06-09 2007-12-13 George Gorodeski Cell collection and disease screening
EP1978106A1 (en) 2007-04-07 2008-10-08 Universitätsklinikum Hamburg-Eppendorf Detection of ESR1 amplification in endometrium cancer and ovary cancer
WO2008137591A2 (en) * 2007-05-02 2008-11-13 Biocept, Inc. Non-invasive detection of endometrial cancer
JP5419195B2 (ja) 2007-08-03 2014-02-19 国立大学法人愛媛大学 頭頸部癌の腫瘍マーカー
WO2009021338A1 (en) 2007-08-15 2009-02-19 UNIVERSITé DE SHERBROOKE Alternative splicing gene variants in cancer detection
US8053198B2 (en) 2007-09-14 2011-11-08 Meso Scale Technologies, Llc Diagnostic methods
WO2009126969A2 (en) 2008-04-11 2009-10-15 Expression Pathology Inc. Biomarkers for endometrial disease
IN2012DN00707A (enExample) * 2009-07-24 2015-06-19 Geadic Biotec Aie

Similar Documents

Publication Publication Date Title
JP2013500001A5 (enExample)
Sanguedolce et al. Urine TMPRSS2: ERG fusion transcript as a biomarker for prostate cancer: literature review
Kamel et al. Investigation of long noncoding RNAs expression profile as potential serum biomarkers in patients with hepatocellular carcinoma
ES2612482T3 (es) Marcadores en la orina para la detección del cáncer de vejiga
HRP20141062T1 (hr) Markeri za rak endometrija
CN102333887B (zh) 用于检测gi癌转移的方法
CN105102636B (zh) 用于检测和测定前列腺癌预后的组合物和方法
Brisuda et al. Urinary cell-free DNA quantification as non-invasive biomarker in patients with bladder cancer
JP2008524998A5 (enExample)
RU2015138992A (ru) Способы прогнозирования риска интерстициальной пневмонии
JP2014516543A5 (enExample)
JP2018527886A5 (enExample)
WO2018097166A1 (ja) Pd-1免疫チェックポイント阻害剤による治療に対するがんの感受性を予測する方法
US20140371081A1 (en) Compositions for and Methods of Detecting, Diagnosing, and Prognosing Thymic Cancer
JP2009539370A5 (enExample)
TWI598444B (zh) 用以評估乳癌罹患風險之方法及基因標記
CN114438208A (zh) 通过外泌体miRNA生物标志物进行肺癌诊断的检测试剂盒和方法
JP6383541B2 (ja) 胆管がんの検出キット及び検出方法
JP2022512634A (ja) Pde4d7及びdhx9発現に基づく術前のリスク層別化
CN110331207A (zh) 肺腺癌生物标志物及相关应用
JP6612509B2 (ja) 大腸癌の予後診断を補助する方法、記録媒体および判定装置
RU2719581C1 (ru) Способ прогнозирования риска рецидивирования у ВПЧ16-позитивных больных с плоскоклеточным интраэпителиальным поражением тяжелой степени на основе определения физического статуса вируса
EP3336547A1 (en) Novel human bladder cancer biomarkers and their diagnostic use
JP6103866B2 (ja) 大腸ガン検出方法、診断用キット及びdnaチップ
Giunchi et al. Urinary biomarkers for prostate cancer